Compugen Ltd (NASDAQ:CGEN)

8.75
Data as of 3:59pm ET
 -0.01 / -0.11%
Today’s Change
7.58
Today|||52-Week Range
14.32
-2.23%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$424.6M

Company Description

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Tel Aviv, Israel.

Contact Information

Compugen Ltd.
72 Pinchas Rosen Street
Tel Aviv -- 69512
P:(723) 765-8585
Investor Relations:

Employees

Shareholders

Other institutional5.00%
Mutual fund holders3.65%
Individual stakeholders--

Top Executives

Anat Cohen-DayagPresident & Chief Executive Officer
Ari KrashinChief Financial Officer
Zurit LevineVice President-Research & Discovery
Tsipi Keren-LehrerVice President-Business Development
Eyal NeriaVice President-Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.